Trial intelligence / Profile preview

Orochem for Erosive Oral Lichen Planus

NCT04336488Phase 1Unknown

Start
Jan 2020
Primary completion
Jun 2020
Countries
1
01

Overview

Phase 1 trial in oral lichen planus (OLP) (2 arms). Primary endpoint: Change in Disease Severity Score at 3 weeks. Status: unknown.

02

Conditions

oral lichen planus (OLP)

Beyond the preview

Go deeper on NCT04336488.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04336488.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call